Chlorthalidone/Reserpine

氯噻酮/利血平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameChlorthalidone/Reserpine
Drug Alias Name氯噻酮+利血平Chlorthalidone●Reserpine氯噻酮-利血平Chlorthalidone-Reserpine mixt氯噻酮●利血平 +[14] 
ClassificationSmall molecules
Mechanisms of ActionThiazide-sensitive sodium-chloride cotransporter inhibitorsSynaptic vesicular amine transporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterSynaptic vesicular amine transporter
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1964/05/08
Country/TerritoryUnited States
CombinationsYes ReserpineChlorthalidone
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A